These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6208152)

  • 1. Monoclonal antibodies: technology and application to gram-negative infections.
    Young LS
    Infection; 1984; 12(4):303-8. PubMed ID: 6208152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies: technology and application to gram-negative infections.
    Young LS
    Infection; 1985; 13 Suppl 2():S224-9. PubMed ID: 3932219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies for treatment of gram-negative infections.
    Young LS; Gascon R; Alam S; Bermudez LE
    Rev Infect Dis; 1989; 11 Suppl 7():S1564-71. PubMed ID: 2690294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.
    Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM
    J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental gram-negative bacterial sepsis with murine monoclonal antibodies directed against lipopolysaccharide.
    Priest BP; Brinson DN; Schroeder DA; Dunn DL
    Surgery; 1989 Aug; 106(2):147-54; discussion 154-5. PubMed ID: 2763023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].
    Rietschel ET; Brade H
    Infection; 1987; 15 Suppl 2():S76-84. PubMed ID: 2440812
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to lipopolysaccharides: some diagnostic and protective aspects.
    Fomsgaard A
    APMIS Suppl; 1990; 18():1-38. PubMed ID: 2122911
    [No Abstract]   [Full Text] [Related]  

  • 8. Production and characterization of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa.
    Lam JS; MacDonald LA; Lam MY; Duchesne LG; Southam GG
    Infect Immun; 1987 May; 55(5):1051-7. PubMed ID: 2437030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies that distinguish inner core, outer core, and lipid A regions of Pseudomonas aeruginosa lipopolysaccharide.
    de Kievit TR; Lam JS
    J Bacteriol; 1994 Dec; 176(23):7129-39. PubMed ID: 7525538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a protective human monoclonal for the treatment of gram-negative sepsis.
    Larrick JW; Gray O; Deinhart T; Wang J; Flatgaard J; Chong KT
    Prog Clin Biol Res; 1988; 272():383-93. PubMed ID: 3393571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of gram-negative bacterial sepsis. A single murine monoclonal antibody provides cross-genera protection.
    Dunn DL; Ewald DC; Chandan N; Cerra FB
    Arch Surg; 1986 Jan; 121(1):58-62. PubMed ID: 3942500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Production and characterization of monoclonal antibodies directed agains the major outer membrane protein and lipopolysaccharide of Chlamydia trachomatis].
    Cuffini C; Becher S; Adamo P; Pedranti M; Zapata M
    Rev Argent Microbiol; 2001; 33(4):203-8. PubMed ID: 11833251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of gram-negative bacteria for Pseudomonas aeruginosa lipoprotein I using a monoclonal antibody.
    Sciortino CV
    Hybridoma; 1993 Jun; 12(3):327-32. PubMed ID: 7689535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis.
    Dunn DL; Bogard WC; Cerra FB
    Surgery; 1985 Aug; 98(2):283-90. PubMed ID: 3895540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].
    Rietschel ET; Brade H
    Infection; 1987; 15(2):133-41. PubMed ID: 2439461
    [No Abstract]   [Full Text] [Related]  

  • 18. Development and potential use of antibody directed against lipopolysaccharide for the treatment of gram-negative bacterial sepsis.
    Dunn DL
    J Trauma; 1990 Dec; 30(12 Suppl):S100-6. PubMed ID: 2254968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a human monoclonal antibody to lipopolysaccharides of Pseudomonas aeruginosa serotype 5: a possible candidate as an immunotherapeutic agent for infections with P. aeruginosa.
    Sawada S; Kawamura T; Masuho Y; Tomibe K
    J Infect Dis; 1985 Nov; 152(5):965-70. PubMed ID: 3930629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
    Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
    Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.